BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32441856)

  • 1. Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registries.
    Chen S; Redfors B; Crowley A; Ben-Yehuda O; Summers M; Hahn RT; Jaber WA; Pibarot P; Alu MC; Chau KH; Kapadia S; Nazif T; Vahl TP; Thourani V; Kodali S; Leon M
    Eur J Heart Fail; 2020 Oct; 22(10):1866-1874. PubMed ID: 32441856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
    Chen S; Redfors B; Nazif T; Kirtane A; Crowley A; Ben-Yehuda O; Kapadia S; Finn MT; Goel S; Lindman BR; Alu MC; Chau KH; Thourani VH; Vahl TP; Douglas PS; Kodali SK; Leon MB
    Eur Heart J; 2020 Feb; 41(8):943-954. PubMed ID: 31711153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
    Chen S; Redfors B; O'Neill BP; Clavel MA; Pibarot P; Elmariah S; Nazif T; Crowley A; Ben-Yehuda O; Finn MT; Alu MC; Vahl TP; Kodali S; Leon MB; Lindman BR
    Eur Heart J; 2020 Feb; 41(8):958-969. PubMed ID: 31883339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of transcatheter aortic valve replacement for patients with severe aortic stenosis and concomitant aortic insufficiency: Insights from the TVT Registry.
    Bhardwaj B; Cohen DJ; Vemulapalli S; Kosinski AS; Xiang Q; Li Z; Allen KB; Kapadia S; Aggarwal K; Sorajja P; Chhatriwalla AK
    Am Heart J; 2020 Oct; 228():57-64. PubMed ID: 32828047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement.
    Auffret V; Bakhti A; Leurent G; Bedossa M; Tomasi J; Belhaj Soulami R; Verhoye JP; Donal E; Galli E; Loirat A; Sharobeem S; Sost G; Le Guellec M; Boulmier D; Le Breton H
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008959. PubMed ID: 32600108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Paravalvular Regurgitation With 1-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve.
    Pibarot P; Hahn RT; Weissman NJ; Arsenault M; Beaudoin J; Bernier M; Dahou A; Khalique OK; Asch FM; Toubal O; Leipsic J; Blanke P; Zhang F; Parvataneni R; Alu M; Herrmann H; Makkar R; Mack M; Smalling R; Leon M; Thourani VH; Kodali S
    JAMA Cardiol; 2017 Nov; 2(11):1208-1216. PubMed ID: 28973091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of transcatheter aortic valve replacement in patients with cardiogenic shock.
    Goel K; Shah P; Jones BM; Korngold E; Bhardwaj A; Kar B; Barker C; Szerlip M; Smalling R; Dhoble A
    Eur Heart J; 2023 Sep; 44(33):3181-3195. PubMed ID: 37350747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Smoking Status With Long-Term Mortality and Health Status After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Qintar M; Li Z; Vemulapalli S; Chhatriwalla AK; Baron SJ; Kosinski AS; Saxon JT; Spertus JA; Cohen DJ; Arnold SV
    J Am Heart Assoc; 2019 Aug; 8(16):e011766. PubMed ID: 31423877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
    Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
    Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, Prognostic Impact, and Predictive Factors of Readmission for Heart Failure After Transcatheter Aortic Valve Replacement.
    Durand E; Doutriaux M; Bettinger N; Tron C; Fauvel C; Bauer F; Dacher JN; Bouhzam N; Litzler PY; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2426-2436. PubMed ID: 29217006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement.
    González Ferreiro R; López Otero D; Álvarez Rodríguez L; Otero García Ó; Pérez Poza M; Antúnez Muiños PJ; Cacho Antonio C; López Pais J; Juskowa M; Cid Álvarez AB; Trillo Nouche R; Sanmartín Pena XC; Sánchez Fernández PL; Cruz-González I; González Juanatey JR
    Circ Cardiovasc Interv; 2021 Feb; 14(2):e009342. PubMed ID: 33541099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry.
    Nazif TM; Dizon JM; Hahn RT; Xu K; Babaliaros V; Douglas PS; El-Chami MF; Herrmann HC; Mack M; Makkar RR; Miller DC; Pichard A; Tuzcu EM; Szeto WY; Webb JG; Moses JW; Smith CR; Williams MR; Leon MB; Kodali SK;
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):60-9. PubMed ID: 25616819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Transcatheter Aortic Valve Replacement for Bicuspid vs Tricuspid Aortic Stenosis and Mortality or Stroke.
    Makkar RR; Yoon SH; Leon MB; Chakravarty T; Rinaldi M; Shah PB; Skipper ER; Thourani VH; Babaliaros V; Cheng W; Trento A; Vemulapalli S; Kapadia SR; Kodali S; Mack MJ; Tang GHL; Kaneko T
    JAMA; 2019 Jun; 321(22):2193-2202. PubMed ID: 31184741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Outcomes of Mitral Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement: Findings From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.
    Joseph L; Bashir M; Xiang Q; Yerokun BA; Matsouaka RA; Vemulapalli S; Kapadia S; Cigarroa JE; Zahr F
    JACC Cardiovasc Interv; 2018 Apr; 11(7):693-702. PubMed ID: 29622149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
    Chen S; Redfors B; Ben-Yehuda O; Crowley A; Greason KL; Alu MC; Finn MT; Vahl TP; Nazif T; Thourani VH; Suri RM; Svensson L; Webb JG; Kodali SK; Leon MB
    JACC Cardiovasc Interv; 2018 Nov; 11(21):2207-2216. PubMed ID: 30409278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prosthetic Valve Endocarditis After TAVR and SAVR: Insights From the PARTNER Trials.
    Summers MR; Leon MB; Smith CR; Kodali SK; Thourani VH; Herrmann HC; Makkar RR; Pibarot P; Webb JG; Leipsic J; Alu MC; Crowley A; Hahn RT; Kapadia SR; Tuzcu EM; Svensson L; Cremer PC; Jaber WA
    Circulation; 2019 Dec; 140(24):1984-1994. PubMed ID: 31690104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
    Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
    Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.